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ABSTRACT
Introduction: Malignant esophageal neoplasia is a rare tumor, but it has high morbidity 
and mortality. Early diagnosis and intensive treatment associated with surgical approach 
remains the best treatment for the disease. Its epidemiology is extremely diverse in 
the world, even in the same country.
Methods: This was a retrospective analysis made from 2000-2015, analyzing the 
mortality rates of malignant esophageal neoplasia in the state of Rio Grande do Sul 
(RS) in its 30 Health Regions and in Brazil. The mortality data were collected in the 
Mortality Information System (SIM) and the population data in the Brazilian Institute 
of Geography and Statistics (IBGE).
Results: The esophageal cancer mortality rate was 8.61 (95% CI, 8.49-8.73) per 
100,000 inhabitants in RS, while the national rate was 3.66 (95% CI, 3, 49-3.82), 
with a significant difference (p <0.0001). The regional distribution was variable, and 
the West Border region presented the highest rate, 12.91 (95% CI, 12.05-13.77). 
However, even regions with lower mortality presented twice as much deaths than the 
national rate. Mortality increased with aging, with the oldest age groups (≥80 years) 
presenting 69.62 (95% CI, 64.9-74) deaths per 100,000 inhabitants.
Conclusion: Esophageal neoplasia is still a very serious condition in the state of RS, 
being associated with an almost 3-fold higher mortality rate compared to the national 
rate. Even within the state different epidemiological patterns are found.
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Malignant neoplasm of esophagus is one of the most malignant tumors. 
It’s the sixth cause of death by cancer in the world and the fourth in male 
mortality in Brazil1,2. It is mainly represented by two histological types, 
adenocarcinoma, which mainly affects the distal third and gastroesophageal 
junction, and squamous cell carcinoma, which occurs mainly in the medial 
third, and these two types represent 95% of the malignant neoplasms of the 
organ3,4.
Nowadays, there was a drastic change in the epidemiology of the two 
histological types. During the last 30 years, especially in the United States and 
Europe, adenocarcinoma had increased its epidemiology and is currently the 
main representative of esophageal cancer in the United States, overcoming 
the squamous cell carcinoma3,5.
Both histological types occur more in men, with adenocarcinoma with 
a ratio of 9:1 in the United States5. The most common risk factors for 
adenocarcinoma are obesity and gastroesophageal reflux disease, both favoring 
the appearance of Barrett’s esophagus, as well as tobacco. For squamous 
cell carcinoma, alcoholism, tobacco and consumption of hot beverages, such 
as teas and hot mate, are corroborated by the high incidence in China due to 
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its culture4,6. The age of the patients at the diagnosis 
of adenocarcinoma is about 53 years, while for the 
squamous cell carcinoma it is 63 years7.
The high aggressiveness is explained by the 
high rate of metastasis and the late diagnosis, when 
the lesions are already very advanced4. Treatment 
is done according to stage, but esophagectomy 
is the gold-standard treatment for curative intent. 
Stage I patients can be treated for isolated surgical 
resection of the lesion, but stage II and III patients 
require neoadjuvant chemotherapy and esophagectomy 
as treatment. In stage IV, the treatment becomes 
palliative, with the aid of procedures to treat the 
dysphagia. At diagnosis, about 60% of the cases 
are contraindicated for surgery due to the advanced 
state of the disease, when it compromises adjacent 
structures or presents with metastases8,9. The overall 
prognosis of survival in five years is just about 17%, 
confirming the severity of the neoplasia10.
It is known that the epidemiology of esophagus 
cancer is variable in the world and can have significant 
differences even within the same country, and Rio 
Grande do Sul (RS) figures as one of states with 
the highest mortality rates in Brazil. This is probably 
due to the culture of drinking hot mate, which is 
consumed at high temperatures, becoming a risk 
factor for squamous cell carcinoma. Even within the 
state the epidemiology is quite variable11.
The objective of the present study was to perform 
an individual evaluation of the mortality of malignant 
esophageal neoplasia in the 30 Health Regions of 
Rio Grande do Sul, comparing them with the state 
and the Brazilian means.
METHODOLOGY
The present study was an epidemiological, 
retrospective and descriptive research related to 
the mortality due to esophageal cancer in the period 
between 2000 and 2015. The study localization was 
defined by the state of Rio Grande do Sul and was 
subdivided in its 30 Health Regions, a division made 
by the state’s Health Secretary. The mortality data 
of Brazil was also analyzed.
Data about the mortality were collected on 
the Mortality Information System (SIM-SUS) 
database, available on the DataSUS website 
(DATASUS - www.datasus.com.br), and the population 
numbers were provided by the Brazilian Institute of 
Geography and Statistics (IBGE - www.ibge.gov.br). 
The SIM-SUS is a public system that collects and 
publishes the absolute number of deaths of each 
disease based on the International Classification of 
Diseases (ICD). This system covers the data from 
the whole country.
The population of the study analyzed included 
patients whose death was attributed to esophageal 
malignancy in the state of Rio Grande do Sul and 
in its 30 Health Regions and in Brazil. Data were 
analyzed and separated according to age group 
(0-9, 10-19 20-29, 30-39, 40-49, 50-59, 60-69, 
70-79 and 80 years or more), sex (female and 
male), and absolute population of each subcategory. 
The mortality rates were represented by each 
100,000 men or women or both. The calculation 
was done by multiplying the gross death numbers by 
100,000 inhabitants and then dividing the results for 
the total population of each group analysis. The rates 
were then adjusted for sex and age.
The statistical analysis was made by the GraphPad 
Prism program version 6 and with spreadsheets 
of Microsoft Office Excel 2016 (United States). 
The statistical comparisons between the years and 
populations were made by the t-student test for 
the parametric variables and Mann-Whitney for the 
non-parametric variables. Significant p-values  of 
each analysis were defined as being less than or 
equal to 0.05 and the confidence interval adopted 
for the study was 95% (95% CI).
The results were presented through maps, graphics 
and tables for better interpretation and exposure 
of the results. The mortality maps were created on 
the Adobe Photoshop CC 2015 software using the 
available map of Health Secretary of Rio Grande do 
Sul, correlating with the data provided by the SUS 
mortality system. Available from: http://www.saude.
rs.gov.br/regioes-de-saude [cited 2018 May 6], and 
the graphics on GraphPad Prism version 6.
RESULTS
A total of 14,927 deaths from malignant esophageal 
neoplasia occurred in RS from 2000 to 2015, 
representing a mortality rate of 8.61 (95% CI, 8.49-8.73) 
deaths per 100,000 inhabitants in the state. Brazil 
had 111,106 deaths in the same period and its 
average mortality rate was 3.66 (95% CI, 3.49-3.82) 
per 100,000 inhabitants. The difference between 
the two rates was significant (p <0.0001), see 
figure 1b.
There is a clear predominance of men 
over women with a 3:1 ratio. The mean age 
of men was 64.6 (95% CI, 64.1-65) years old 
and 70.2 (95% CI, 69.7-70.75) for women 
in RS. The mortality rates adjusted by sex 
were 13.10 and 4.28 for every 100,000 men and 
women, respectively.
Mortality rates were progressively higher for 
older age groups, with the peak found for both 
sexes at ≥ 80 years, with 117.99 (95% CI, 109-126.6) 
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deaths per 100,000 men and 44.93 (95% CI, 41.3-48.7) 
for women. Extremely rare cases occurred under 
the age of 40, see figure 1a.
It was observed that there were significant 
reductions (p <0.05) in mortality rates for some age 
groups analyzed during the years 2000 to 2015, 
male populations between 50-59, 60-69, 70-79 
had 37, 29, 27 percent drop, respectively. While in 
the female group only the age group above eighty 
years showed a fall of 68 percent.
When analyzed for the geographical differences of 
the RS state (Figure 2), there was a great disparity in 
mortality rates. The western part of the state had the 
highest mortality rates of the neoplasia. The Health 
Region that had the highest mortality rate was the 
West Border region, with 12,91/100,000 deaths 
(95% CI: 12.05-13.77), while the lowest rates were 
found in the Capital/Gravataí region – 6,54/100,000 
(95% CI: 6.26-6.82). All regions had at least twice 
as many deaths as the national average, which was 
3.66 (95% CI, 3.49-3.82) per 100,000.
Figure 2: Mortality rates of esophageal cancer in the 30 Health Regions of Rio Grande do Sul from 2000 to 2015.
Figure 1: Differences on the mortality rates of esophageal cancer per 100,000 inhabitants comparing men and women 
(a) and Brazil and Rio Grande do Sul (b).
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DISCUSSION
The results show that Rio Grande do Sul is an 
endemic region for malignant esophageal neoplasia, 
since its mortality is almost three times higher than 
the national level. In addition, the state presents a 
different national and international epidemiological 
pattern. Analysis of the worldwide literature indicates 
an increase in the number of cases and mortality rates 
of esophageal malignancy mainly in America and 
Europe, most of all due to an increase in risk factors for 
esophageal adenocarcinoma, such as obesity, GERD 
and Barrett’s esophagus5-7. In a national analysis, RS 
shows rates three times higher than Brazil, and this 
trend has remained over the years.
This fact can be explained by different cultural patterns 
that the region presents. The practice of drinking hot 
mate is presented as one of the risk factors, increasing 
by 160 percent the incidence in a meta-analysis12. 
The consumption and preparation of the herb may 
also be responsible. The consumption of hot drinks 
(> 60oC) is a factor of esophageal mucosa lesion and 
oncogenesis, and in addition, due to the fact that the 
herb preparation underwent a drying process on the 
fire, polycyclic aromatic hydrocarbons carcinogens - 
also present in the cigarette - was found in the urine 
of individuals who regularly consume the drink11,13,14.
It is noticed that the epidemiological pattern of this 
neoplasia is changing over time in the state. A retrospective 
study with a similar methodology, analyzing the years 
1979-1989, showed that state rates had increased 
during that period15. However, this study demonstrates 
a significant decrease for older age groups, possibly 
due to declines in risk factors, such as smoking and 
alcoholism, associated with better treatments of the 
disease, such as the use of neoadjuvant therapies16.
In Asia, there is an endemic region that extends 
from Iran, China and Russia called “Asian Esophageal 
Cancer Belt” in which the highest rates of incidence and 
mortality of esophageal squamous cell carcinoma are 
found worldwide. In this region, the incidence reaches 
100 cases per 100,000 inhabitants. This numbers can be 
explained by their diet costumes, like the consumption 
of hot drinks and pickled vegetables. Because of the 
high incidence, programs of screening were implanted 
in these countries for an early detection of esophageal 
cancer1,17. The mortality rate in China in 2012 was 
15.58 deaths for 100,000 inhabitants18.
Malignant neoplasm of the esophagus has a high 
mortality rate, reaching only 20% of survival in 5 years10,19, 
and 60% of the patients have an unresectable disease 
at the time of diagnosis9. Considering this lethality, 
mortality analysis data can infer epidemiological patterns, 
since diagnostic and mortality rates tend to be similar.
According to the National Cancer Institute (INCA)20, 
the different treatments depend on the stage of the 
disease. For early tumors, the curative treatment can 
be done by endoscopic resection, but it is very rare 
because of the late diagnosis. Intermediate levels of 
the disease are treated with esophagectomy surgery 
and for advanced stages the treatment is only palliative 
with chemotherapy, radiotherapy, endoscopic dilatations 
or esophageal prostheses in order to relieve some 
consequences like dysphagia and poor nutrition. Rohde 
and Osvaldt9, authors of a book on digestive surgery 
based on the experience of one of the biggest hospitals 
in Rio Grande do Sul, defines the treatment for each 
TNM standard: local resection for stage I patients, 
esophagectomy and chemotherapy for stage II and III, 
and palliative for stage IV patients.
This study has some limitations concerning the 
database that provided the mortality information. The SIM 
system provides secondary data that does not allow 
the researcher to control possible taping and registry 
mistakes. Besides, there can also be under notification 
on the deaths that occurred during the period. However, 
this database provides official information and its filing 
is mandatory in the whole country, thus the results can 
be trusted.
As a conclusion, esophageal cancer in Rio Grande 
do Sul remains extremely worrying. With all Health 
Regions presenting higher means than the Brazilian 
average, and a mean mortality rate in the state almost 
three times higher than the national rate, it is clear that the 
situation is alarming, especially on the western regions, 
where the numbers show an extremely high mortality.
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